Literature DB >> 2473404

Fibronectin inhibits the terminal differentiation of human keratinocytes.

J C Adams1, F M Watt.   

Abstract

In the epidermis proliferation of keratinocytes is restricted to the basal layer, which is in contact with the basement membrane, and cells undergo terminal differentiation as they move upwards through the suprabasal layers. In stratified cultures of human keratinocytes, upward migration is a consequence, not a cause, of terminal differentiation and occurs because keratinocytes become less adhesive to their substratum and to one another. Most keratinocytes can be induced to differentiate to completion by placing them in suspension in methylcellulose: within 12 h DNA synthesis is irreversibly inhibited and by 24 h most cells express involucrin (ref 4; P. A. Hall, J.C.A. and F.M.W., unpublished observations). Here we report that when fibronectin is added to the methylcellulose, keratinocytes still withdraw from the cell cycle, but induction of involucrin expression is largely inhibited. The effect of fibronectin is concentration- and time-dependent and is mediated by a receptor of the integrin family. These results provide an explanation for why overt terminal differentiation is normally restricted to suprabasal cells, whereas cell-cycle withdrawal occurs within the basal layer; they also have important implications for the mechanism of epidermal wound healing. Furthermore, our data show that the binding of an extracellular matrix protein to its receptor can regulate differentiated gene expression in the absence of changes in cell shape.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473404     DOI: 10.1038/340307a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  102 in total

1.  Migration of keratinocytes through tunnels of digested fibrin.

Authors:  V Ronfard; Y Barrandon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms.

Authors:  L Levy; S Broad; D Diekmann; R D Evans; F M Watt
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

Review 3.  Role of integrins in regulating epidermal adhesion, growth and differentiation.

Authors:  Fiona M Watt
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

4.  Specific and shared targets of ephrin A signaling in epidermal keratinocytes.

Authors:  Rebecca Walsh; Miroslav Blumenberg
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

5.  Capture by chemical crosslinkers provides evidence that integrin alpha IIb beta 3 forms a complex with protein tyrosine kinases in intact platelets.

Authors:  D J Dorahy; M C Berndt; G F Burns
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

6.  Localization of integrin subunits alpha 6 and beta 1 during somitogenesis in the long-tailed macaque (M. fascicularis).

Authors:  C S Pow; A G Hendrickx
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

7.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.

Authors:  R W Hurley; J B McCarthy; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Carbodiimide conjugation of fibronectin on collagen basal lamina analogs enhances cellular binding domains and epithelialization.

Authors:  Katie A Bush; George D Pins
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

9.  Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation.

Authors:  D F Fischer; S Gibbs; P van De Putte; C Backendorf
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Expression of the integrin-linked kinase (ILK) in mouse skin: loss of expression in suprabasal layers of the epidermis and up-regulation by erbB-2.

Authors:  W Xie; F Li; J E Kudlow; C Wu
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.